← Back to Search

Post-Operative Phone Follow-Up for Reducing Hospital Readmissions

N/A
Recruiting
Led By Syed Husain, MBBS
Research Sponsored by Syed Husain
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age greater than 18 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

This trial will compare the effectiveness of two different protocols for follow-up care after colorectal surgery. The aim is to identify ways to improve discharge and follow-up care within 30 days of surgery.

Who is the study for?
Adults over 18 who've had colorectal surgery at The Ohio State University Wexner Medical Center can join. It's not for those under 18, with communication issues, or without a phone.Check my eligibility
What is being tested?
The trial is testing if a phone call check-up 3 days after colorectal surgery is better than the usual care of a follow-up visit two weeks post-op in reducing hospital readmissions within 30 days.See study design
What are the potential side effects?
Since this study involves follow-up procedures rather than medication, there are no direct side effects from interventions like drugs. However, stress or anxiety related to post-operative care could be indirectly affected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post-Operative Phone Call (assess readmission rates)
Secondary outcome measures
Post Discharge Survey (assess patient satisfaction)

Side effects data

From 2020 Phase 4 trial • 84 Patients • NCT02459964
2%
Headache
100%
80%
60%
40%
20%
0%
Study treatment Arm
Treatment Arm 1 (Intranasal Fentanyl)
Treatment Arm 2 (Intravenous Hydromorphone)
No Medication Administered

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Phone CallExperimental Treatment1 Intervention
The experimental group will receive a phone call intervention 3 days post-op. During this phone call, the patient will be asked questions using a study questionnaire based on the most frequent indications for readmission post colorectal surgery. Based on the responses, patients will be advised to maintain the scheduled appointment, visit the clinic within 48 hours, or go to the Emergency Department immediately.
Group II: Standard of CareActive Control1 Intervention
The control will be discharged with standard of care follow-up instructions and scheduled for a standard follow-up clinic visit within 2-3 weeks post-op.

Find a Location

Who is running the clinical trial?

Syed HusainLead Sponsor
1 Previous Clinical Trials
100 Total Patients Enrolled
1 Trials studying Postoperative Complications
100 Patients Enrolled for Postoperative Complications
Syed Husain, MBBSPrincipal Investigator - OSU Wexner Medical Center
Ohio State University Hospital - Wexner Medical Center, Richard M. Ross Heart Hospital
1 Previous Clinical Trials
100 Total Patients Enrolled
1 Trials studying Postoperative Complications
100 Patients Enrolled for Postoperative Complications

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the maximal number of participants for this medical trial?

"Affirmative. According to clinicaltrials.gov, this investigation into novel treatments is currently recruiting patients; it was originally publicized on June 19th 2018 and has since been updated April 19th 2022. 480 individuals are needed at a single study site for the trial to reach completion."

Answered by AI

Are there any openings for patients to join this clinical experiment currently?

"Affirmative. Data accessible on clinicaltrials.gov affirms that this medical trial, which was first posted in June 19th 2018, is currently seeking participants to enroll. 480 patients need to be recruiter from a single medical facility."

Answered by AI
~7 spots leftby Jun 2024